Evaluating immune response in vitro in a relevant microenvironment: a high-throughput microfluidic model for clinical screening

AIM: Functional screening of new pharmaceutical compounds requires clinically relevant models to monitor essential cellular and immune responses during cancer progression, with or without treatment. Beyond survival, the emergence of resistant tumor cell clones should also be considered, including sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Doffe, Flora, Fuoco, Layla, Michels, Judith, Jernström, Sandra, Tomasi, Raphael, Savagner, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834268/
https://www.ncbi.nlm.nih.gov/pubmed/36654822
http://dx.doi.org/10.37349/etat.2022.00117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834268/
https://www.ncbi.nlm.nih.gov/pubmed/36654822
http://dx.doi.org/10.37349/etat.2022.00117

Ejemplares similares